NEURO-PUPILLARY INDEX

What this means for you

This application is over — abandoned 04 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98243863

Mark type

Stylized text

Filed

27 Oct 2023

Abandoned

04 Sept 2024

Attorney of record

John Paul Oleksiuk

Goods and services

• Class 009 — Scientific and electric apparatus: Biometric software for pupillometry and eye tracking measurement; Software as a medical device (SaMD), downloadable, for the diagnosis of balance disorders by recording, viewing, or analyzing pupillometry and eye movements tracking; Downloadable computer software for controlling and managing patient medical information; Pupillometry software; Medical devices, namely, pupilometers; Downloadable computer software using machine learning software for healthcare purposes; Downloadable computer software for medical apparatus used in pupillometry; Downloadable computer software for monitoring pupillometry biomarkers; Downloadable computer software for monitoring of neurological and neurodegenerative diseases; Computer hardware and downloadable software for pupillometry and collecting eye-tracking data; Computer hardware and software for analyzing and reporting pupillometry and eye-tracking data for the purposes of assessing individuals' performance, for making recommendations to improve individuals' performance, and for predictive modeling and analytics, for use in scientific research, and for use in marketing
• Class 042 — Scientific and technological services: Laboratory Research in the field of pupillometry and eye tracking; Technological research in the field of pupillometry and eye tracking; Research relating to the development of new products and medical services; Design, engineering, research, development and testing service in the field of pupillometry and eye tracking for medical, scientific, and technological applications; Scientific and technological healthcare monitoring services including neurological status of patient, namely, in the field of pupillometry and eye tracking; Research and development services in connection with pupillometry and eye tracking; Medical research; Design and development of medical diagnostic apparatus; Scientific and medical research relating to the diagnosis and treatment of neurological and neurodegenerative diseases; Scientific and medical research relating to the development of non-invasive diagnostic methods based on pupillometry; Scientific and medical research, in the fields of Ophthalmology, Optics and Optometry; Scientific and medical research relating to searching of new biomarkers
• Class 044 — Medical, beauty and agricultural services: Medical services; Medical analysis services relating to the treatment and diagnosis of persons; Remote monitoring of medical data for medical diagnosis and treatment; Medical screening in the following fields: Diagnosis and treatment of neurological and neurodegenerative diseases; Medical services relating to pupillometry; Monitoring of patient condition using pupillometers; Medical services relating to disease progression by non-invasive methods; Medical services, in the fields of Ophthalmology, Optics and Optometric services; Medical diagnostic services relating to the use of pupillometry biomarkers

Owner

• Solvemed Group sp. z o.o., Poznan, PL

Prosecution history

• 16 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 16 Jul 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
• 16 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 16 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 16 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 16 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 17 Sept 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 17 Sept 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 03 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 03 Jun 2024 — NON-FINAL ACTION E-MAILED
• 03 Jun 2024 — NON-FINAL ACTION WRITTEN
• 22 May 2024 — ASSIGNED TO EXAMINER
• 06 Nov 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 31 Oct 2023 — NEW APPLICATION ENTERED